Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Prognostic factors in pemphigus vulgaris and pemphigus foliaceus.

Saha M, Bhogal B, Black MM, Cooper D, Vaughan RW, Groves RW.

Br J Dermatol. 2014 Jan;170(1):116-22. doi: 10.1111/bjd.12630.

PMID:
24102444
2.
3.

Comparison of diagnostic value of indirect immunofluorescence assay and desmoglein ELISA in the diagnosis of pemphigus.

Marinović B, Fabris Z, Lipozencić J, Stulhofer Buzina D, Lakos Jukić I.

Acta Dermatovenerol Croat. 2010;18(2):79-83.

PMID:
20624356
4.

Correlation of immunological profile with phenotype and disease outcome in pemphigus.

Herrero-González JE, Iranzo P, Benítez D, Lozano F, Herrero C, Mascaró JM Jr.

Acta Derm Venereol. 2010 Jul;90(4):401-5. doi: 10.2340/00015555-0868.

5.

Human leukocyte antigen genotypes and antibody profiles associated with familial pemphigus in Japanese.

Yamamoto T, Ikeda K, Sasaoka S, Yamasaki O, Fujimoto W, Aoyama Y, Iwatsuki K.

J Dermatol. 2011 Jul;38(7):711-6. doi: 10.1111/j.1346-8138.2010.01057.x. Epub 2010 Sep 17.

PMID:
21352303
6.

Desmoglein 1 and 3 enzyme-linked immunosorbent assay in Iranian patients with pemphigus vulgaris: correlation with phenotype, severity, and disease activity.

Daneshpazhooh M, Chams-Davatchi C, Khamesipour A, Mansoori P, Taheri A, Firooz A, Mortazavi H, Esmaili N, Dowlati Y.

J Eur Acad Dermatol Venereol. 2007 Nov;21(10):1319-24.

PMID:
17958835
7.

Comparison of desmoglein 1 and 3 enzyme-linked immunosorbent assay and direct immunofluorescence for evaluation of immunological remission in pemphigus vulgaris.

Daneshpazhooh M, Kamyab K, Kalantari MS, Balighi K, Naraghi ZS, Shamohammadi S, Mortazavizadeh SM, Ramezani A, Chams-Davatchi C.

Clin Exp Dermatol. 2014 Jan;39(1):41-7. doi: 10.1111/ced.12187. Epub 2013 Jun 19.

PMID:
23782219
8.

The clinical transition between pemphigus foliaceus and pemphigus vulgaris correlates well with the changes in autoantibody profile assessed by an enzyme-linked immunosorbent assay.

Komai A, Amagai M, Ishii K, Nishikawa T, Chorzelski T, Matsuo I, Hashimoto T.

Br J Dermatol. 2001 Jun;144(6):1177-82.

PMID:
11422038
9.

Clinical and immunological profile of umbilical involvement in pemphigus vulgaris and pemphigus foliaceus.

Oliveira Júnior JV, Maruta CW, Sousa JX Jr, Santi CG, Valente NY, Ichimura LM, Périgo AM, Aoki V.

Clin Exp Dermatol. 2013 Jan;38(1):20-4. doi: 10.1111/j.1365-2230.2012.04468.x. Epub 2012 Oct 22.

PMID:
23083306
10.

Monitoring disease activity in pemphigus with enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3.

Cheng SW, Kobayashi M, Kinoshita-Kuroda K, Tanikawa A, Amagai M, Nishikawa T.

Br J Dermatol. 2002 Aug;147(2):261-5.

PMID:
12174096
11.

Serum and salivary desmoglein 1 and 3 enzyme-linked immunosorbent assay in pemphigus vulgaris: correlation with phenotype and severity.

Hallaji Z, Mortazavi H, Lajevardi V, Tamizifar B, AmirZargar A, Daneshpazhooh M, Chams-Davatchi C.

J Eur Acad Dermatol Venereol. 2010 Mar;24(3):275-80. doi: 10.1111/j.1468-3083.2009.03408.x. Epub 2009 Aug 26.

PMID:
19709345
12.

Diagnosis of pemphigus by ELISA: a critical evaluation of two ELISAs for the detection of antibodies to the major pemphigus antigens, desmoglein 1 and 3.

Harman KE, Gratian MJ, Seed PT, Bhogal BS, Challacombe SJ, Black MM.

Clin Exp Dermatol. 2000 May;25(3):236-40.

PMID:
10844505
13.

Detection of pemphigus autoantibodies by IIF and ELISA tests in patients with pemphigus vulgaris and foliaceus and in healthy relatives.

Torzecka JD, Narbutt J, Sysa-Jedrzejowska A, Waszczykowska E, Lukamowicz J, Pas HH.

Med Sci Monit. 2003 Dec;9(12):CR528-33.

PMID:
14646976
14.

Tunisian endemic pemphigus foliaceus is associated with the HLA-DR3 gene: anti-desmoglein 1 antibody-positive healthy subjects bear protective alleles.

Abida O, Zitouni M, Kallel-Sellami M, Mahfoudh N, Kammoun A, Ben Ayed M, Masmoudi A, Mokni M, Fezzaa B, Ben Osman A, Kammoun MR, Turki H, Makni H, Gilbert D, Joly P, Tron F, Makni S, Masmoudi H; Franco-Tunisian Group for Survey and Research on Pemphigus.

Br J Dermatol. 2009 Sep;161(3):522-7. doi: 10.1111/j.1365-2133.2009.09207.x. Epub 2009 Apr 10.

PMID:
19486004
15.

Novel ELISA systems for antibodies to desmoglein 1 and 3: correlation of disease activity with serum autoantibody levels in individual pemphigus patients.

Schmidt E, Dähnrich C, Rosemann A, Probst C, Komorowski L, Saschenbrecker S, Schlumberger W, Stöcker W, Hashimoto T, Bröcker EB, Recke A, Rose C, Zillikens D.

Exp Dermatol. 2010 May;19(5):458-63. doi: 10.1111/j.1600-0625.2010.01069.x. Epub 2010 Feb 16.

PMID:
20163452
16.
17.

Comparative study of pemphigus vulgaris and pemphigus foliaceus in Singapore.

Goon AT, Tan SH.

Australas J Dermatol. 2001 Aug;42(3):172-5.

PMID:
11488709
18.

Study of desmoglein 1 and 3 antibody levels in relation to disease severity in Indian patients with pemphigus.

Kumar B, Arora S, Kumaran MS, Jain R, Dogra S.

Indian J Dermatol Venereol Leprol. 2006 May-Jun;72(3):203-6.

19.

HLA class II polymorphism contributes to specify desmoglein derived peptides in pemphigus vulgaris and pemphigus foliaceus.

Loiseau P, Lecleach L, Prost C, Lepage V, Busson M, Bastuji-Garin S, Roujeau JC, Charron D.

J Autoimmun. 2000 Aug;15(1):67-73.

PMID:
10936030
20.

A higher correlation of the antibody activities against the calcium-dependent epitopes of desmoglein 3 quantified by ethylenediaminetetraacetic acid-treated enzyme-linked immunosorbent assay with clinical disease activities of pemphigus vulgaris.

Kamiya K, Aoyama Y, Shirafuji Y, Hamada T, Morizane S, Fujii K, Iwatsuki K.

J Dermatol Sci. 2013 Jun;70(3):190-5. doi: 10.1016/j.jdermsci.2013.02.011. Epub 2013 Mar 15.

PMID:
23602628

Supplemental Content

Support Center